Tech
Deciphex, an Irish company that develops software to accelerate the delivery of pathology services, has raised $11.5 million from backers that include pharma giant Novartis and contact research organisation Charles River Laboratories. Dublin-based Act Venture Capital led the latest financing which brings total funding to date for Deciphex to $19.5 million. Other participants in the Series B found include Irrus Investments, Nextsteps Capital and the HBAN Medtech Syndicate.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: